IR
Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
Disclosure
Total of 10posts
Number | Title | Person with Duty to Submit | Receipt Date |
---|---|---|---|
10 | Other Management Information(Voluntary Disclosure)(소규모합병 승인 이사회결의(주주총회 갈음) 결과 보고) | 2024-04-11 | |
9 | Outcomes of Annual Meeting of Shareholders | 2024-03-28 | |
8 | Submission of Audit Report | 2024-03-20 | |
7 | [Revised]Other Management Information(Voluntary Disclosure)(국책과제 선정(아데노바이러스 벡터 플랫폼 기반 COVID-19 변이에 대한 다가백신 개발)) | 2024-03-15 | |
6 | Decision on Merger(소규모합병) | 2024-03-12 | |
5 | Other Management Information(Voluntary Disclosure)(전자투표제 도입 결정) | 2024-03-07 | |
4 | Resolutions for Convocation of General Meeting of Shareholders | 2024-03-07 | |
3 | 30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations) | 2024-03-07 | |
2 | [Revised]Contract for Sales or Supply | 2024-02-01 | |
1 | Outcome of Asset Revaluation(Voluntary Disclosure) | 2024-01-03 |